CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Rosemary T. Smith - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Rosemary T. Smith

OPENALEX: A5054763432↗ORCID: 0000-0002-0314-8372↗

Affiliations

Organizations

Cognitive Neuroimaging Labauthorship · FR McLean Hospitalauthorship · US

Public evidence

3 connected articles

Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, High-Cannabidiol Product in Patients with Anxiety: An Open-Label Pilot Study.2025 · Europe PMC Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment.2022 · PubMed Central Open Access Contemplating cannabis? The complex relationship between cannabinoids and hepatic metabolism resulting in the potential for drug-drug interactions.2022 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.